Asia Biosimilars Summit 2011 covers topics such as:
- Feasibility of accessing the Asian biosimilars markets
- Regulatory guidelines for Asia biosimilars
- Marketing strategies and commercialisation of biosimilar products into market
- Partnerships, strategic alliances and collaborations in Asia
- Process technology: production process to reduce cost to maximise product margin
- Product quality, drug safety and efficacy – comparable to original biologics
- How attractive is biosimilars to Big Pharma?
Asia Biosimilars Summit 2011 brings together VPs, CEO, Directors, Heads of Biologics, Research & Development, Strategic Planning, Business Development, Licensing, Market Access, Product Development, Sales & Marketing, Legal/Patent? IP, Regulatory Affairs, CEO/VP/MD/Principal, Commercial, Manufacturing Director, R&D Director/ CSO, Quality Director, Medical Affairs, Drug Safety / Pharmacovigi and Clinical Trial.
